Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

KANSU E., Ward D., Sanchez A. P., Cunard R., HAYRAN K. M., Huseyin B., et al.
HEMATOLOGY , cilt.27, sa.1, ss.785-794, 2022 (SCI-Expanded) identifier identifier identifier

miRNA Expression Profiling in Mesenchymal Stromal Stem Cells Derived from G CSF Primed Bone Marrows

GÜNEL ÖZCAN A., Cagnan I., Kansu E., ÇETİNKAYA F. D.
Blood , cilt.124, 2014 (SCI-Expanded)

The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells

Bozkurt S., Ozkan T., ÖZMEN F., Baran Y., Sunguroglu A., Kansu E.
HEMATOLOGY , cilt.18, sa.4, ss.217-223, 2013 (SCI-Expanded) identifier identifier identifier

Deep Vein Thrombosis Following Non-myeloablative Allogeneic Stem Cell Transplantation: Presentation of Three Cases and Literature Review

Ozdemir E., Kansu E.
TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.2, ss.188-190, 2013 (SCI-Expanded) Creative Commons License identifier identifier identifier

Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia

BOZKURT S., Uz B., BÜYÜKAŞIK Y., BEKTAŞ Ö., Inanc A., GÖKER H., et al.
MEDICAL ONCOLOGY , cilt.30, sa.1, 2013 (SCI-Expanded) identifier identifier identifier

The effect of granulocyte colony stimulating factor receptor gene missense single nucleotide polymorphisms on peripheral blood stem cell enrichment

CAMURDANOGLU B. Z., ESENDAĞLI G., Ozdemir E., CANPINAR H., Guc D., Kansu E.
CYTOKINE , cilt.61, sa.2, ss.572-577, 2013 (SCI-Expanded) identifier identifier identifier

Impact of Lymphatic Vessel Invasion on Survival in Gastric Cancer

ÖZMEN F., ÖZMEN M. N., Kansu E.
JOURNAL OF GASTROINTESTINAL SURGERY , cilt.16, sa.8, ss.1637-1638, 2012 (SCI-Expanded) identifier identifier identifier

Thrombosis in stem cell transplantation

Kansu E.
HEMATOLOGY , cilt.17, 2012 (SCI-Expanded) identifier identifier identifier

Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-beta in patients with laryngeal squamous cell carcinoma

GÜNAYDIN R. Ö., KESİKLİ S. A., KANSU E., HOŞAL A. Ş.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.34, sa.3, ss.393-397, 2012 (SCI-Expanded) identifier identifier identifier

P16 and p27 tumor suppressor gene methylation status in childhood Wilms tumor cases

Bozkurt C., BOZKURT S., Arda N., Ertem A. U., Sahin G., Yuksek N., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.41, sa.4, ss.633-638, 2011 (SCI-Expanded) Creative Commons License identifier identifier

Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer

ÖZMEN F., OZMEN M. M., Ozdemir E., MORAN M., SECKIN S., Guc D., et al.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.17, sa.27, ss.3220-3228, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Immune Compartmentalization of T cell Subsets in Chemically-induced Breast Cancer

Fahmi T., ESENDAĞLI G., Yilmaz G., Kansu E., Guc D.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , cilt.72, sa.4, ss.339-348, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Late relapse of a light-chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem-cell transplantation

Ozdemir E., BAYRAKTAR M., SÖKMENSÜER C., Kir K. M., Kansu E.
CLINICAL TRANSPLANTATION , cilt.23, sa.6, ss.981-984, 2009 (SCI-Expanded) identifier identifier identifier

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

Oyan B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.
CLINICAL TRANSPLANTATION , cilt.23, sa.6, ss.839-847, 2009 (SCI-Expanded) identifier identifier identifier

Transfection of myeloid leukaemia cell lines is distinctively regulated by fibronectin substratum

ESENDAĞLI G., CANPINAR H., DOĞAN A., Akkaya M., Kansu E., Guc D.
CYTOTECHNOLOGY , cilt.61, ss.45-53, 2009 (SCI-Expanded) Creative Commons License identifier identifier identifier

Fibronectin promotes the phorbol 12-myristate 13-acetate-induced macrophage differentiation in myeloid leukemia cells

ESENDAĞLI G., CANPINAR H., Yilmaz G., KAYMAZ F. F., Kansu E., Guc D.
INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.89, sa.2, ss.167-172, 2009 (SCI-Expanded) identifier identifier identifier

Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene

ESENDAĞLI G., CANPINAR H., Yilmaz G., Gunel-Ozcan A., Guc M. O., Kansu E., et al.
CANCER BIOLOGY & THERAPY , cilt.8, sa.2, ss.136-142, 2009 (SCI-Expanded) identifier identifier identifier

The Lollipop with Strawberry Aroma May Be Promising in Reduction of Infusion-Related Nausea and Vomiting during the Infusion of Cryopreserved Peripheral Blood Stem Cells

Ozdemir E., AKGEDIK K., AKDOGAN S., Kansu E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , cilt.14, sa.12, ss.1425-1428, 2008 (SCI-Expanded) identifier identifier identifier

Adhesion of beta1 integrin to fibronectin regulates CAM-DR phenotype via p21(WAF1/cip1) in HL60 acute myeloid leukemia (AML) cells

CANPINAR H., ESENDAĞLI G., Kansu E., Ozcan A. G., Guc D.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.38, sa.2, ss.97-104, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma

OYAN B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.
LEUKEMIA & LYMPHOMA , cilt.47, sa.8, ss.1545-1552, 2006 (SCI-Expanded) identifier identifier identifier

Salmonella typhimurium aroB encoding murine IL 18 or CD40L evaluation for gene therapy

AYDIN D., GÜNEL ÖZCAN A., MENAGER N., ESENDAĞLI G., GÜÇ M. O., HAYRAN K. M., et al.
Febs Journal , cilt.273, ss.49-50, 2006 (SCI-Expanded) identifier identifier

Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis

Ozdemir E., KOC Y., KANSU E.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.81, sa.6, ss.474, 2006 (SCI-Expanded) identifier identifier identifier

Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation

OYAN B., KOC Y., Ozdemir E., KARS A., TURKER A., TEKUZMAN G., et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , cilt.11, sa.9, ss.688-697, 2005 (SCI-Expanded) identifier identifier identifier

Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients - One year follow-up results

KARABUDAK R., KURNE A., GUC D., Sengelen M., CANPINAR H., KANSU E.
JOURNAL OF NEUROLOGY , cilt.251, sa.3, ss.279-283, 2004 (SCI-Expanded) identifier identifier identifier

Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)

OYAN ULUÇ B., Tekuzman G., BARIŞTA İ., Ozisik Y., kars A., Turker A., et al.
ANNALS OF ONCOLOGY , cilt.15, ss.153, 2004 (SCI-Expanded) identifier

pTARGET vector carrying IL 18 or CD40L genes for attenuated Salmonella typhimurium mediated gene therapy

BEK D., ESENDAĞLI G., GÜNEL ÖZCAN A., GÜÇ D., GÜÇ M. O., Kansu E.
Blood , cilt.102, ss.491, 2003 (SCI-Expanded)

Immune alterations in lead-exposed workers

Undeger U., Basaran N., Canpinar H., Kansu E.
TOXICOLOGY , cilt.109, ss.167-172, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

HUMORAL AND CELLULAR IMMUNE PARAMETERS IN UNTREATED AND PHENYTOIN-TREATED OR CARBAMAZEPINE-TREATED EPILEPTIC PATIENTS

BASARAN N., HINCAL F., KANSU E., CIGER A.
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY , cilt.16, sa.12, ss.1071-1077, 1994 (SCI-Expanded) identifier identifier

SERUM IMMUNOGLOBULINS, COMPLEMENT LEVELS AND LYMPHOCYTE SUBPOPULATIONS IN PHENYTOIN-TREATED EPILEPTIC PATIENTS

BASARAN N., KANSU E., HINCAL F.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , cilt.11, ss.335-346, 1989 (SCI-Expanded) identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

2015 Nobel Kimya Ödülü nün önemi DNA Onarımı ve Kanser

GÜNEL ÖZCAN A., Kansu E.
Herkese Bilim Teknoloji , 2016 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

Report of the Policy Conference Concerning the Research and Clinical Use of Stem Cells

KANSU E., Oto A.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.34, sa.7, ss.459-460, 2006 (ESCI) identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Maximal exercise capacity and related factors in patients with breast cancer

VARDAR YAĞLI N., SAĞLAM M., İNAL İNCE D., ÇALIK KÜTÜKCÜ E., ARIKAN H., Sener G., et al.
European-Respiratory-Society (ERS) International Congress, Madrid, İspanya, 28 Eylül - 02 Ekim 2019, cilt.54 Sürdürülebilir Kalkınma identifier

Pulmonary function, respiratory muscle strength and activities of daily life in breast cancer survivors

ÇAKMAK A., SONBAHAR ULU H., Firat M., VARDAR YAĞLI N., SAĞLAM M., ÇALIK KÜTÜKCÜ E., et al.
European-Respiratory-Society (ERS) International Congress, Madrid, İspanya, 28 Eylül - 02 Ekim 2019, cilt.54 Sürdürülebilir Kalkınma identifier

IL 32 and IL 21 gene expression levels in patients with colon cancer

ERDEM G. Ö., ÖZMEN F., ÖZMEN M. M., KULAÇOĞLU S., KANSU E.
4th European Congress of Immunology, 6 - 09 Eylül 2015 Sürdürülebilir Kalkınma

miRNA Expression Profiling in Mesenchymal Stromal/Stem Cells Derived from G-CSF Primed Bone Marrows

ÖZCAN A., Cagnan I., KANSU E., Uckan D.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124 identifier

ASSOCIATION BETWEEN HLA ALLELES AND JAK2 V617F MUTATION IN POLYCYTHEMIA VERA

ÖZMEN F., Goren G., GÜÇ D., KANSU E.
Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, Birleşik Krallık, 31 Mayıs - 03 Haziran 2012, cilt.79, ss.577 identifier

Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone

ÖZDEMİR E., Koc Y., Kars A., Turker A., Tekuzman G., KANSU E.
49th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2007, cilt.110 identifier

High resolution MHC class-I related chain a (MICA) genotyping and analysis of HLA-B - MICA haplotypes in a Turkish population sample

Yigitbas E., Dong L., Wei-Zi D., Coruh S., Goren G., ÜNER A., et al.
32nd Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics, California, Amerika Birleşik Devletleri, 16 - 20 Ekim 2006, cilt.67 identifier

Metrikler

Yayın

38

Atıf (WoS)

283

H-İndeks (WoS)

10

Atıf (Scopus)

261

H-İndeks (Scopus)

9

Atıf (Scholar)

31

H-İndeks (Scholar)

4

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları